Compare Stocks → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:CPUHNYSE:CRHCNASDAQ:DCFCNASDAQ:HERA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPUHCompute Health Acquisition$10.36-2.1%$10.46$9.70▼$10.94$318.67M0.0239,058 shs41,500 shsCRHCCohn Robbins$9.77$7.85▼$10.05$1.04B0.02562,596 shs32 shsDCFCTritium DCFC$0.89-75.5%$15.46$1.35▼$304.00$752K1.12111,089 shs204,342 shsHERAFTAC Hera Acquisition$10.19$10.18$9.73▼$10.20$1.11B0.011.01 million shs883,449 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPUHCompute Health Acquisition0.00%0.00%0.00%0.00%-0.10%CRHCCohn Robbins0.00%0.00%0.00%0.00%0.00%DCFCTritium DCFC0.00%-5.21%-69.46%-87.27%-98.30%HERAFTAC Hera Acquisition0.00%0.00%0.00%0.00%0.00%Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo ClinicMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCPUHCompute Health AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACRHCCohn RobbinsN/AN/AN/AN/AN/AN/AN/AN/ADCFCTritium DCFC3.3717 of 5 stars3.05.00.00.02.11.70.0HERAFTAC Hera AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPUHCompute Health AcquisitionN/AN/AN/AN/ACRHCCohn RobbinsN/AN/AN/AN/ADCFCTritium DCFC2.00Hold$300.0033,607.87% UpsideHERAFTAC Hera AcquisitionN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPUHCompute Health AcquisitionN/AN/A$1.50 per share6.90($0.38) per shareN/ACRHCCohn RobbinsN/AN/AN/A28.83($0.63) per shareN/ADCFCTritium DCFC$184.54M0.00N/AN/A($187.67) per share0.00HERAFTAC Hera AcquisitionN/AN/A$0.06 per share181.63($0.46) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPUHCompute Health Acquisition$32.37MN/A0.00∞N/AN/A-23.80%1.31%N/ACRHCCohn Robbins$35.90MN/A0.00N/AN/AN/A-17.29%1.44%N/ADCFCTritium DCFC-$121.37MN/A0.00∞N/AN/AN/AN/AN/AHERAFTAC Hera Acquisition$6.11MN/A0.00∞N/AN/A-60.37%2.80%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPUHCompute Health AcquisitionN/AN/AN/AN/AN/ACRHCCohn RobbinsN/AN/AN/AN/AN/ADCFCTritium DCFCN/AN/AN/AN/AN/AHERAFTAC Hera AcquisitionN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPUHCompute Health AcquisitionN/A0.130.13CRHCCohn RobbinsN/A0.010.01DCFCTritium DCFCN/AN/AN/AHERAFTAC Hera AcquisitionN/A0.010.01OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPUHCompute Health Acquisition15.27%CRHCCohn Robbins69.99%DCFCTritium DCFC8.27%HERAFTAC Hera Acquisition72.45%Insider OwnershipCompanyInsider OwnershipCPUHCompute Health Acquisition20.00%CRHCCohn Robbins20.00%DCFCTritium DCFC27.20%HERAFTAC Hera Acquisition20.88%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCPUHCompute Health Acquisition230.76 million24.61 millionNot OptionableCRHCCohn Robbins1103.50 millionN/ANot OptionableDCFCTritium DCFC818845,000615,000OptionableHERAFTAC Hera AcquisitionN/A108.83 million86.11 millionNot OptionableCPUH, HERA, DCFC, and CRHC HeadlinesSourceHeadlineWhat Kind Of Shareholders Hold The Majority In FTAC Hera Acquisition Corp.'s (NASDAQ:HERA) Shares?finance.yahoo.com - June 24 at 4:12 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioViking Therapeutics Surges Sentiment for Triple Threat GLP-1PillApril 3, 2024 6:20 AMView Viking Therapeutics Surges Sentiment for Triple Threat GLP-1PillAkebia Therapeutics Surges on FDA Approval for Anemia TreatmentApril 3, 2024 9:10 AMView Akebia Therapeutics Surges on FDA Approval for Anemia TreatmentCan Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? April 9, 2024 6:07 AMView Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?April 22, 2024 6:05 AMView Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?All Headlines Company DescriptionsCompute Health AcquisitionNYSE:CPUHCompute Health Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Wilmington, Delaware.Cohn RobbinsNYSE:CRHCCohn Robbins Holdings Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was formerly known as CSR Acquisition Corp. Cohn Robbins Holdings Corp. was incorporated in 2020 and is based in Wilmington, Delaware.Tritium DCFCNASDAQ:DCFCTritium DCFC Limited designs, manufactures, and supplies direct current chargers for electric vehicles in Australia and internationally. The company's charging station hardware portfolio includes various standalone chargers and distributed chargers. Its service and maintenance portfolio includes warranties, service level agreements, and sales of spare parts. The company operates a service management software platform; and provides high-power charging sessions. It serves charge point operators, automakers, electric vehicle fleets, and fuel stations, as well as retail and utility sectors. Tritium DCFC Limited was founded in 2001 and is based in Murarrie, Australia.FTAC Hera AcquisitionNASDAQ:HERAFTAC Hera Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Philadelphia, Pennsylvania. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.